October 2022, Vol 309, No 7966
Compassionate medicine schemes help patients with cancer live better and for longer — why are they not more widely used?
Top news stories
‘Worrying’ rise in number of patients with a high anticholinergic burden
Stop recruiting GP pharmacists, community pharmacy negotiator tells minister
Features
Drug-gene interaction testing may be about to go mainstream
Missed opportunities: the patients falling through the cracks after discharge
Infographic: the rise of independent prescribers
This month’s podcast
In this episode of The PJ Pod, the team look at the potential implications of anticholinergic drug use, particularly in older people, and examine the case for deprescribing.
Opinion
PJ view: All pharmacists should have the opportunity to become a prescriber
Compassionate medicine schemes help patients with cancer live better and for longer — why are they not more widely used?
Putting medicines shortages into perspective
Closing the MPharm awarding gap
The role of pharmacists in increasing patient access to ‘compassionate use’ programmes
Learning & CPD
How to conduct a clinical audit in six steps
Supporting patients on new direct oral anticoagulant medicines
Complex decision-making for foundation and newly qualified pharmacists
Herbal medicines in pregnancy
Research
Errors and the inappropriate use of medicines in UK care homes
Clinical impact of CFTR modulator therapy roll-out
Your RPS
National Pharmacy Board meeting: 29 September 2022
Pharmacy closures debate is ‘undermining public confidence’, says RPS Scotland director
Sibby Buckle: ‘Even if it is uncomfortable, I am prepared to voice my concerns’
Scottish health minister backs protected learning time for pharmacists
